Whole Health Study: A Randomized Trial of Collaborative Care for People with Opioid Use Disorder and Psychiatric Disorder
October 22 @ 12:00 pm - 1:30 pm
CBH is excited to welcome Dr. David Mandell, Director of the Penn Center of Mental Health, to present on the Whole Health Study.
Opioid use and overdose has increased dramatically since 2010, leading to significant morbidity and mortality. Several collaborative models for Opioid Use Disorder (OUD) treatment in primary care have been proposed, although few have been rigorously tested. While these models vary, all comprise a team-based approach in which a primary care physician is waivered to prescribe buprenorphine and a care manager coordinates care. Collaborative care for mental health also is increasingly common, but most primary care practices have not embraced similar models for OUD.
The proposed study takes place in the University of Pennsylvania Health System (Penn), which has 88 primary care practices serving more than 500,000 patients in urban, suburban, and rural areas. Our specific aims are:
- Conduct a randomized study of three care conditions with to determine which is most effective
in improving outcomes for people with OUD and mental health conditions:
- Augmented usual care (UC): PCP waivered to prescribe buprenorphine and an existing mental health care manager
- Collaborative Care (CC): Waiver PCP; mental health care manager receives OUD training; practice receives telephonic psychiatrist consultation
- Collaborative Care + Peer Recovery Specialist to address social determinants of health;
- Measure clinician and organizational-level factors associated with implementation of each component; and
- Conduct a cost evaluation of each of the three care models.